Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Extended Range HRP Microwell Substrate Launched

By LabMedica International staff writers
Posted on 18 Jul 2012
AACC 2012: An extended range horseradish peroxidase (HRP) microwell substrate was launched at the American Association for Clinical Chemistry (AACC) show in Los Angeles (CA, USA), taking place from July 15-19, 2012.

A product of SurModics (Eden Prairie, MN, USA), the BioFX TMB extended range HRP microwell substrate (TMBX), when used in a quantitative assay, increases the assay's upper limit of quantization and maintains the detection limits and analytical sensitivity achieved with other TMB substrates. More...
TMBX also improves the reproducibility of the assay through lower backgrounds and better control of assay timing.

TMBX is SurModic's slowest kinetic option of TMB substrates for extended dynamic range and improved reproducibility within. It is a colorimetric substrate for HRP detection in microwell applications. TMBX is a one-component substrate that requires no preparation prior to use.

The right substrate can make a substantial contribution to the overall sensitivity of an assay. SurModics offers a variety of colorimetric TMB substrates and complementary novel stop solutions, available in both bulk and custom dispenses.

SurModics' offers new surface modification technologies and in vitro diagnostic chemical components. Core offerings include surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities, and components for in vitro diagnostic tests and microarrays.

Related Links:

SurModics




Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Collection and Transport System
PurSafe Plus®
8-Channel Pipette
SAPPHIRE 20–300 µL
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.